References
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148:639–651.e28. https://doi.org/10.1053/j.gastro.2015.01.031.
Participants in the Paris Workshop. The Paris classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003;58:S3–S43.
Choi CR, Ignjatovic-Wilson A, Askari A, et al. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer. Am J Gastroenterol. 2015;110:1461–1471. https://doi.org/10.1038/ajg.2015.248.
Thomas T, Abrams KA, Robinson RJ, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–668.
Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2:534–541. https://doi.org/10.1016/S1542-3565(04)00237-X.
Sanduleanu S, Kaltenbach T, Barkun A, et al. Roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83:212–222.
Naymagon S, Ullman TA. Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: past, present, and future. Gastroenterol Hepatol. 2015;11:304–311.
Lopez A, Collet-Fenetrier B, Belle A, Peyrin-Biroulet L. Patients’ knowledge and fear of colorectal cancer risk in inflammatory bowel disease: colorectal cancer risk in IBD. J Dig Dis. 2016;17:383–391. https://doi.org/10.1111/1751-2980.12356.
Baars JE, Siegel CA, van’t Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis. 2010;42:777–784.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Lewin, S.M., Wen, K.W., Velayos, F.S. et al. How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease. Dig Dis Sci 64, 52–55 (2019). https://doi.org/10.1007/s10620-018-5409-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-018-5409-5